Artwork

Вміст надано AGORACOM. Весь вміст подкастів, включаючи епізоди, графіку та описи подкастів, завантажується та надається безпосередньо компанією AGORACOM або його партнером по платформі подкастів. Якщо ви вважаєте, що хтось використовує ваш захищений авторським правом твір без вашого дозволу, ви можете виконати процедуру, описану тут https://uk.player.fm/legal.
Player FM - додаток Podcast
Переходьте в офлайн за допомогою програми Player FM !

Small Cap Breaking News: Don’t Miss Today’s Top Headlines 01/13/2025

17:01
 
Поширити
 

Manage episode 461009090 series 3179537
Вміст надано AGORACOM. Весь вміст подкастів, включаючи епізоди, графіку та описи подкастів, завантажується та надається безпосередньо компанією AGORACOM або його партнером по платформі подкастів. Якщо ви вважаєте, що хтось використовує ваш захищений авторським правом твір без вашого дозволу, ви можете виконати процедуру, описану тут https://uk.player.fm/legal.

Here’s a quick rundown of the latest updates from standout small-cap companies making big moves today:

GoldHaven Resources Corp. (CSE: GOH) Expands Portfolio with Strategic Acquisition of Boa

Gold Corp.GoldHaven Resources Corp. (CSE: GOH) (OTCQB: GHVNF) (FSE: 4QS) has successfully acquired Boa Gold Corp., adding four highly prospective mining projects in Brazil to its portfolio. This strategic move aligns with the company’s mission to expand in Brazil’s thriving mining sector, a region known for its substantial production of critical minerals. The Copeçal Gold Project, a key component, includes extensive exploration-ready targets and proven anomalies. CEO Bonn Smith highlights the immense potential for shareholder value as GoldHaven prepares to commence its drill program in mid-2025.

Rakovina Therapeutics Inc. (TSX-V: RKV) Achieves Milestone in AI-Driven Cancer Drug

DiscoveryRakovina Therapeutics Inc. (TSX-V: RKV) has reached a significant milestone in its quest to revolutionize cancer treatment. By leveraging AI-driven drug discovery, the Vancouver-based biopharmaceutical company has successfully shortlisted AI-designed molecules targeting ATR (Ataxia Telangiectasia and Rad3-related protein), with the ability to penetrate the central nervous system (CNS). This advancement holds promise for improved therapies for cancers affecting the brain and CNS, areas previously lacking effective treatment options. The partnership with Variational AI has accelerated drug development timelines and enhanced precision targeting, setting a new standard in oncology research.

Adcore Inc. (TSX: ADCO) Continues Strong Growth in 2025

Adcore Inc. (TSX: ADCO), a leader in AI-powered marketing technology, has begun 2025 on a high note. The Toronto-based company reported a significant 61% increase in its cash position, reaching CAD $10.8 million as of December 31, 2024. This robust financial foundation, coupled with rapid growth in its Media Blast app, which achieved a nearly CAD $2 million Annual Recurring Revenue (ARR) in just six months, showcases Adcore’s ability to innovate and scale effectively. Additionally, the upcoming launch of Proposaly.io, a sales enablement app, highlights Adcore’s commitment to diversifying its product offerings and advancing its technological solutions.

Voyageur Pharmaceuticals Ltd. (TSX.V: VM) Leads Innovation in Radiology with New Barium Contrast Products

Voyageur Pharmaceuticals (TSX.V: VM) is setting a new standard in medical imaging with its innovative barium contrast product line. The company has initiated human testing for these advanced formulations, with plans for a full market launch in 2025. By leveraging its 100% natural barium resource from the Frances Creek barite project, Voyageur aims to alleviate global supply chain constraints while offering superior-quality contrast agents. Key products like SmoothHD®, SmoothLD®, VisionHD®, and SmoothX® are designed to enhance diagnostic accuracy, patient comfort, and procedural efficiency. CEO Brent Willis highlighted the transformative potential, noting that 2025 will be a pivotal year for Voyageur as they expand beyond Canada into international markets.

Goliath Resources Limited (TSX.V: GOT) Discovers High-Grade Gold in Golden Triangle

Goliath Resources (TSX.V: GOT) is making headlines with its latest drill results from the 100% controlled Golddigger Property in British Columbia’s Golden Triangle. The company has reported significant findings, expanding high-grade gold mineralization zones and reinforcing its potential for a world-class gold discovery. Key highlights include intersections of up to 34.52 g/t AuEq over 39 meters in the Bonanza Zone, showcasing exceptional mineralization.

For more breaking small-cap news and updates, make sure to follow AGORACOM on our podcast: https://open.spotify.com/AGORACOM.

  continue reading

737 епізодів

Artwork
iconПоширити
 
Manage episode 461009090 series 3179537
Вміст надано AGORACOM. Весь вміст подкастів, включаючи епізоди, графіку та описи подкастів, завантажується та надається безпосередньо компанією AGORACOM або його партнером по платформі подкастів. Якщо ви вважаєте, що хтось використовує ваш захищений авторським правом твір без вашого дозволу, ви можете виконати процедуру, описану тут https://uk.player.fm/legal.

Here’s a quick rundown of the latest updates from standout small-cap companies making big moves today:

GoldHaven Resources Corp. (CSE: GOH) Expands Portfolio with Strategic Acquisition of Boa

Gold Corp.GoldHaven Resources Corp. (CSE: GOH) (OTCQB: GHVNF) (FSE: 4QS) has successfully acquired Boa Gold Corp., adding four highly prospective mining projects in Brazil to its portfolio. This strategic move aligns with the company’s mission to expand in Brazil’s thriving mining sector, a region known for its substantial production of critical minerals. The Copeçal Gold Project, a key component, includes extensive exploration-ready targets and proven anomalies. CEO Bonn Smith highlights the immense potential for shareholder value as GoldHaven prepares to commence its drill program in mid-2025.

Rakovina Therapeutics Inc. (TSX-V: RKV) Achieves Milestone in AI-Driven Cancer Drug

DiscoveryRakovina Therapeutics Inc. (TSX-V: RKV) has reached a significant milestone in its quest to revolutionize cancer treatment. By leveraging AI-driven drug discovery, the Vancouver-based biopharmaceutical company has successfully shortlisted AI-designed molecules targeting ATR (Ataxia Telangiectasia and Rad3-related protein), with the ability to penetrate the central nervous system (CNS). This advancement holds promise for improved therapies for cancers affecting the brain and CNS, areas previously lacking effective treatment options. The partnership with Variational AI has accelerated drug development timelines and enhanced precision targeting, setting a new standard in oncology research.

Adcore Inc. (TSX: ADCO) Continues Strong Growth in 2025

Adcore Inc. (TSX: ADCO), a leader in AI-powered marketing technology, has begun 2025 on a high note. The Toronto-based company reported a significant 61% increase in its cash position, reaching CAD $10.8 million as of December 31, 2024. This robust financial foundation, coupled with rapid growth in its Media Blast app, which achieved a nearly CAD $2 million Annual Recurring Revenue (ARR) in just six months, showcases Adcore’s ability to innovate and scale effectively. Additionally, the upcoming launch of Proposaly.io, a sales enablement app, highlights Adcore’s commitment to diversifying its product offerings and advancing its technological solutions.

Voyageur Pharmaceuticals Ltd. (TSX.V: VM) Leads Innovation in Radiology with New Barium Contrast Products

Voyageur Pharmaceuticals (TSX.V: VM) is setting a new standard in medical imaging with its innovative barium contrast product line. The company has initiated human testing for these advanced formulations, with plans for a full market launch in 2025. By leveraging its 100% natural barium resource from the Frances Creek barite project, Voyageur aims to alleviate global supply chain constraints while offering superior-quality contrast agents. Key products like SmoothHD®, SmoothLD®, VisionHD®, and SmoothX® are designed to enhance diagnostic accuracy, patient comfort, and procedural efficiency. CEO Brent Willis highlighted the transformative potential, noting that 2025 will be a pivotal year for Voyageur as they expand beyond Canada into international markets.

Goliath Resources Limited (TSX.V: GOT) Discovers High-Grade Gold in Golden Triangle

Goliath Resources (TSX.V: GOT) is making headlines with its latest drill results from the 100% controlled Golddigger Property in British Columbia’s Golden Triangle. The company has reported significant findings, expanding high-grade gold mineralization zones and reinforcing its potential for a world-class gold discovery. Key highlights include intersections of up to 34.52 g/t AuEq over 39 meters in the Bonanza Zone, showcasing exceptional mineralization.

For more breaking small-cap news and updates, make sure to follow AGORACOM on our podcast: https://open.spotify.com/AGORACOM.

  continue reading

737 епізодів

All episodes

×
 
Loading …

Ласкаво просимо до Player FM!

Player FM сканує Інтернет для отримання високоякісних подкастів, щоб ви могли насолоджуватися ними зараз. Це найкращий додаток для подкастів, який працює на Android, iPhone і веб-сторінці. Реєстрація для синхронізації підписок між пристроями.

 

Короткий довідник

Слухайте це шоу, досліджуючи
Відтворити